Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

To assess whether changes in electrical impedance - measured using an electrical impedance tomography (EIT) chest belt - can be used to derive changes in pulmonary artery pressure (PAP) in critically ill patients when compared to invasive gold-standard PAP measured using pulmonary artery catheter (PAC).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18-year-old.

Intubated patients in the ICU with clinical decision to monitor PAP and cardiac output using a PAC.

Disqualifiers

Patients with implanted or external thoracic electronic devices (e.g., pacemaker) or thoracic metal implants.

Known pregnancy or lactating patients.

Open lung injuries or pneumothorax.

Open wounds, drainages, burns or rashes of the upper thorax.

Trial population

For this study the investigators plan to enroll 28 patients with complete datasets for evaluation of PAP derived by PAC and EIT for a minimum duration of 4 hours in the ICU at Inselspital (Bern) with clinical decision to monitor PAP using a PAC.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • Electrical impedance tomography

    Device

    In addition to routine critical care with a pulmonary artery catheter already in place (PAC), an electrical impedance tomography (EIT) belt will be placed in patients enrolled in this study. Data will be analyzed offline and clinical trajectory and/or decisions will not be impacted by this additional monitoring. EIT is a non-invasive, safe, and radiation-free medical imaging modality.

Treatment groups

28 Participants
are divided into 1 treatment group
Group A: All Study Participants1 intervention

Trial outcomes

Primary outcomes

1

Mean difference between EIT-derived and PAC-measured changes in pulmonary artery pressure

The primary outcome is the difference - expressed as mean and standard deviation (SD) - between changes in EIT-derived pulmonary artery pressure (ΔPAP\_EIT), derived from changes in the pulmonary pulse arrival time, and changes in pulmonary artery catheter-based pulmonary artery pressure (ΔPAP\_PAC). This will be measured over recording periods of up to 48 hours.

Time frame
Up to 48 hours

Secondary outcomes

1

Data acceptance rate

Data acceptance rate, i.e., the percentage of total recording duration during which lung EIT signals show pulmonary pressure morphology and thus allow to estimate EIT-derived PAP values.

Time frame
Up to 48 hours
2

Concordance rate (%) of directional changes in pulmonary artery pressure between EIT and PAC measurements (Trending ability)

The trending ability will be assessed using four quadrant plot analysis to calculate the concordance rate between EIT-derived and PAC-measured pulmonary artery pressure changes. The concordance rate is defined as the percentage of data points in which both methods agree on the direction of change (increase or decrease) in pulmonary artery pressure.

Time frame
Up to 48 hours
3

Accuracy and trending ability of EIT-derived cardiac output compared to PAC measurements

The difference between EIT-derived cardiac output (CO\_EIT) and pulmonary artery catheter-based cardiac output (CO\_PAC) will be calculated. This will be expressed as mean difference ± standard deviation in L/min. The ability of EIT to track changes in cardiac output over time will be evaluated by comparing directional changes in CO\_EIT with corresponding changes in CO\_PAC. This will be reported as the percentage of concordant directional changes between the two methods.

Time frame
Up to 48 hours
4

Agreement between EIT-derived and ventilator-measured respiratory parameters

This outcome assesses the ability of EIT to measure key respiratory parameters compared to the mechanical ventilator measurements. The difference between EIT-derived tidal volume and ventilator-measured tidal volume as well as the difference between EIT-derived respiratory rate and ventilator-measured respiratory rate will be calculated and expressed as mean difference ± standard deviation. Other ventilation-related parameters: Additional parameters such as end-expiratory lung volume changes or regional ventilation distribution may also be assessed, depending on the capabilities of the EIT system and the available ventilator data.

Time frame
Up to 48 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Insel Gruppe AG, University Hospital Bern

Lead sponsor

CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement

Collaborator